JP2024512573A5 - - Google Patents
Info
- Publication number
- JP2024512573A5 JP2024512573A5 JP2023558552A JP2023558552A JP2024512573A5 JP 2024512573 A5 JP2024512573 A5 JP 2024512573A5 JP 2023558552 A JP2023558552 A JP 2023558552A JP 2023558552 A JP2023558552 A JP 2023558552A JP 2024512573 A5 JP2024512573 A5 JP 2024512573A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- chimeric polypeptide
- cell
- recombinant
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163164995P | 2021-03-23 | 2021-03-23 | |
| US63/164,995 | 2021-03-23 | ||
| PCT/US2022/021352 WO2022204151A1 (en) | 2021-03-23 | 2022-03-22 | Synthetic intermembrane proteolysis receptors for custom antigen-induced transcriptional regulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512573A JP2024512573A (ja) | 2024-03-19 |
| JP2024512573A5 true JP2024512573A5 (enExample) | 2025-03-28 |
Family
ID=83397827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558552A Pending JP2024512573A (ja) | 2021-03-23 | 2022-03-22 | カスタム抗原誘導性転写制御のための合成膜間タンパク質分解受容体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240181057A1 (enExample) |
| EP (1) | EP4314038A4 (enExample) |
| JP (1) | JP2024512573A (enExample) |
| CN (1) | CN117255799A (enExample) |
| AU (1) | AU2022244245A1 (enExample) |
| CA (1) | CA3213044A1 (enExample) |
| WO (1) | WO2022204151A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024140778A1 (zh) * | 2022-12-27 | 2024-07-04 | 科济生物医药（上海）有限公司 | Nkg2d工程化细胞及其组合物 |
| EP4701654A2 (en) * | 2023-04-25 | 2026-03-04 | Arsenal Biosciences, Inc. | Novel receptors for transcription regulation |
| WO2026055533A1 (en) * | 2024-09-06 | 2026-03-12 | The Regents Of The University Of California | Synthetic receptors for engineered ligands |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020199218A1 (en) * | 1999-08-19 | 2002-12-26 | Daphne Goring | Proline-rich extensin-like receptor kinases |
| EP3262166A4 (en) * | 2015-02-24 | 2018-08-15 | The Regents of The University of California | Binding-triggered transcriptional switches and methods of use thereof |
| JP7012645B2 (ja) * | 2016-01-11 | 2022-01-28 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | キメラタンパク質および免疫治療の方法 |
| CA3034093A1 (en) * | 2016-08-23 | 2018-03-01 | The Regents Of The University Of California | Proteolytically cleavable chimeric polypeptides and methods of use thereof |
| US12410417B2 (en) * | 2016-10-24 | 2025-09-09 | Northwestern University | Modular extracellular sensor architecture for regulating genes |
| EP3755712A1 (en) * | 2018-02-21 | 2020-12-30 | Cell Design Labs, Inc. | Chimeric transmembrane receptors and uses thereof |
| CN112654346B (zh) * | 2018-07-10 | 2024-06-07 | 加利福尼亚大学董事会 | 生物分子包覆颗粒和薄膜及其用途 |
| WO2021061862A1 (en) * | 2019-09-24 | 2021-04-01 | The Regents Of The University Of California | Notch receptors with hinge domain |
| CN114728174A (zh) * | 2019-09-24 | 2022-07-08 | 加利福尼亚大学董事会 | 具有异源跨膜结构域的受体 |
-
2022
- 2022-03-22 CA CA3213044A patent/CA3213044A1/en active Pending
- 2022-03-22 WO PCT/US2022/021352 patent/WO2022204151A1/en not_active Ceased
- 2022-03-22 JP JP2023558552A patent/JP2024512573A/ja active Pending
- 2022-03-22 AU AU2022244245A patent/AU2022244245A1/en active Pending
- 2022-03-22 US US18/552,141 patent/US20240181057A1/en active Pending
- 2022-03-22 EP EP22776476.8A patent/EP4314038A4/en active Pending
- 2022-03-22 CN CN202280032798.0A patent/CN117255799A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022548796A5 (enExample) | ||
| FI4034252T3 (fi) | Saranadomeenin sisältäviä Notch-reseptoreita | |
| JP2024511423A5 (enExample) | ||
| JP2021512635A5 (enExample) | ||
| Chen et al. | Bispecific antibodies in cancer immunotherapy | |
| Felices et al. | Generation of BiKEs and TriKEs to improve NK cell-mediated targeting of tumor cells | |
| JP2021518142A5 (enExample) | ||
| JP2021502104A5 (enExample) | ||
| JP2022525478A5 (enExample) | ||
| JP2020516287A5 (enExample) | ||
| JP2019537433A5 (enExample) | ||
| JP2019523630A5 (enExample) | ||
| WO2022222910A1 (zh) | 靶向gprc5d的抗体及其用途 | |
| JP2015527070A5 (enExample) | ||
| WO2022170280A2 (en) | Novel anti-cd24 antibodies | |
| JP2024534471A5 (enExample) | ||
| JP2022542559A5 (enExample) | ||
| JP2025106309A5 (enExample) | ||
| JP2023521519A5 (enExample) | ||
| WO2023274303A1 (zh) | 调控细胞生理活动的嵌合多肽 | |
| WO2022111405A1 (zh) | 靶向Claudin18.2的抗体及其用途 | |
| Hayashi et al. | A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells | |
| CN114437214B (zh) | 靶向lir1的抗体及其用途 | |
| US20230399627A1 (en) | Vector genetically engineered with chimeric antigen receptor and against two or more targets and application thereof | |
| CN114075287B (zh) | 人源化bcma抗体和bcma-car-t细胞 |